Zoono Group Ltd (ASX: ZNO) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Zoono Group Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$9.24 million
P/E Ratio
28.90
Dividend Yield
0.00%
Shares Outstanding
355.43 million
Earnings per share
-0.029
Dividend per share
0.03
Year To Date Return
-22.49%
Earnings Yield
3.46%
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Zoono Group Ltd (ASX: ZNO)
Latest News
Share Market News
This ASX biotech share just posted 144% half year revenue growth
Share Market News
Why the Zoono share price rocketed another 25% today
Share Market News
Why this small cap biotech has rocketed 2,511% in the last 5 months
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 04 Sep 2020 | $0.0300 | 0.00% | Final | 21 Sep 2020 |
ZNO ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Zoono Group Ltd
Zoono Group Ltd is engaged in the research, development, and sale of a range of antimicrobial products in multiple countries. The company develops products suited for skin care, surface sanitizers, aerosol-based sprays, as well as acne products, and mold remediation treatments. Geographically, it derives a majority of its revenue from Australasia, Asia, the United States, and India, and also has a presence in the United Kingdom and Europe.
ZNO Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 15 Nov 2024 | $0.03 | $0.00 | 0.00% | 21,324 | $0.03 | $0.03 | $0.03 |
| 14 Nov 2024 | $0.03 | $0.00 | 0.00% | 6,135 | $0.03 | $0.03 | $0.03 |
| 13 Nov 2024 | $0.03 | $0.00 | 0.00% | 219,590 | $0.03 | $0.03 | $0.03 |
| 12 Nov 2024 | $0.03 | $0.00 | 0.00% | 428,274 | $0.03 | $0.03 | $0.03 |
| 08 Nov 2024 | $0.03 | $0.00 | 0.00% | 2,653 | $0.03 | $0.03 | $0.03 |
| 07 Nov 2024 | $0.03 | $0.00 | 0.00% | 37,423 | $0.03 | $0.03 | $0.03 |
| 06 Nov 2024 | $0.03 | $0.00 | 0.00% | 38,922 | $0.03 | $0.03 | $0.03 |
| 05 Nov 2024 | $0.03 | $0.00 | 0.00% | 238,773 | $0.03 | $0.03 | $0.03 |
| 04 Nov 2024 | $0.03 | $0.00 | 0.00% | 478,763 | $0.03 | $0.03 | $0.03 |
| 01 Nov 2024 | $0.03 | $0.00 | 0.00% | 237,133 | $0.03 | $0.03 | $0.03 |
| 31 Oct 2024 | $0.03 | $0.00 | 0.00% | 263,322 | $0.03 | $0.03 | $0.03 |
| 30 Oct 2024 | $0.03 | $0.00 | 0.00% | 188,107 | $0.03 | $0.03 | $0.03 |
| 28 Oct 2024 | $0.03 | $0.00 | 0.00% | 7,245 | $0.03 | $0.03 | $0.03 |
| 25 Oct 2024 | $0.03 | $0.00 | 0.00% | 57,010 | $0.03 | $0.03 | $0.03 |
| 24 Oct 2024 | $0.03 | $0.00 | 0.00% | 50,017 | $0.03 | $0.03 | $0.03 |
| 23 Oct 2024 | $0.03 | $0.00 | 0.00% | 105,000 | $0.03 | $0.03 | $0.03 |
| 22 Oct 2024 | $0.03 | $0.00 | 0.00% | 10,000 | $0.03 | $0.03 | $0.03 |
| 21 Oct 2024 | $0.03 | $0.00 | 0.00% | 856,856 | $0.03 | $0.03 | $0.03 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 10 May 2024 | Donald Clarke | Issued | 168,750 | $4,556 |
Rights issue.
|
| 10 May 2024 | Elissa Hansen | Issued | 166,875 | $4,505 |
Rights issue.
|
| 10 May 2024 | Paul Hyslop | Issued | 30,000,000 | $810,000 |
Rights issue.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Donald Ian Clarke | Non-Executive Director | Apr 2017 |
Mr Clarke was a Partner of Minter Ellison's Melbourne Corporate Group, from 1988- 2015. He currently acts as a consultant to them. Don has advised corporate clients on corporation law issues focused on equity capital markets, private equity, mergers and acquisitions and corporate restructures. He is able to draw on his first-hand experience as a corporate lawyer and a Director, of Directors' duties and responsibilities and best practice corporate governance, when advising on the legal and practical issues faced at head office and board level. He is chair of Risk Committee. Directorships of other listed companies in the past three years - Non-Executive Director, Webjet Limited (appointed January 2008).
|
| Ms Elissa Hansen | Company SecretaryNon Executive Director | Aug 2015 |
Ms Hansen has over 20 years of experience advising boards and management on corporate governance, compliance, investor relations and other corporate related issues. She brings best practice governance advice, ensuring compliance with the Listing Rules, Corporations Act and other relevant legislation. She is member of the Risk Committee. Directorships of other listed companies in the past three years - Non-Executive Director, QMines Limited (appointed August 2020); Non-executive Director, Aeeris Limited (appointed May 2022).
|
| Mr Paul Hyslop | Managing Director | Apr 2017 |
Mr Hyslop, prior to establishing Zoono, was involved in several entrepreneurial ventures ranging from the establishment of a successful private car sales business in Auckland in 1990, to real estate development and business brokerage. He also set up a franchise business in the USA 2002 - 2005. Extremely adept at dealing with businesses and consumers alike, he co-established the Business Brokerage Division at Bayley's Real Estate - one of the real estate and business brokerages in New Zealand. Paul's experience in business development dates back to the 1970s, when he started a personal-care services business after high school, grew it into eight locations and later sold it to his employees. He has also been a commercial flying instructor and Airline pilot, having flown commuter planes for Eagle Air, owned by Air New Zealand.
|
| Mr Barry Woolcott | Global General ManagerChief Executive Officer | Mar 2022 |
-
|
| Paul Ravlich | Chief Financial Officer |
-
|
|
| Lew MacKinnon | Chief Operating Officer |
-
|
|
| Barry Woolcott | Global General ManagerChief Executive Officer |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Paul Russell Hyslop & Margaret Jane Morgan & Npt Meg Trustee Limited <Meg A/C> | 104,447,500 | 29.57% |
| BNP Paribas Noms Pty Ltd | 36,335,278 | 10.29% |
| Citicorp Nominees Pty Limited | 23,217,468 | 6.57% |
| Mr Eelco Wiersma | 17,493,204 | 4.95% |
| UBS nominees Pty Ltd | 10,141,649 | 2.87% |
| Stephen Henesy | 6,214,286 | 1.76% |
| Yasin Shariff | 6,214,286 | 1.76% |
| Marissa Tacy Muirhead | 4,118,889 | 1.17% |
| Mr Theophilos Papantoniou | 4,100,000 | 1.16% |
| Lewis Andrew Craig Mackinnon | 3,867,131 | 1.09% |
| HSBC Custody Nominees (Australia) Limited Gsco Eca | 3,600,000 | 1.02% |
| Lordmax Pty Ltd <Al Fund A/C> | 3,000,000 | 0.85% |
| Ms Marie Tania Genn | 2,873,585 | 0.81% |
| Pw And Vj Cooper Pty Limited <P W & V J Cooper S/F A/C> | 2,592,592 | 0.73% |
| Mr Andrew Moffa & Mrs Sonia Moffa <The Moffa Superfund A/C> | 2,592,592 | 0.73% |
| Mrs Catherine Anne Marson & Mr Joseph Marson <The Marson Family S/F A/C> | 2,222,222 | 0.63% |
| Loosemore Investments Pty Ltd <Loosemore Invest Family A/C> | 2,222,222 | 0.63% |
| Mr Ronald Duje Vela | 1,951,852 | 0.55% |
| Woolcott Investments Limited <The Woolcott Investment A/C> | 1,886,792 | 0.53% |
| Sargram Investments Pty Ltd <Sargram Super A/C> | 1,851,852 | 0.52% |
